Image via Wikipedia
Nerve stem cell transplants may help slow the progression of macular degeneration, the most common cause of blindness in the developed world, U.S. researchers said on Monday.
They said putting nerve stem cells from StemCells Inc near the retinas of rats with a form of macular degeneration helped keep the disease from advancing to blindness for several months.
“These cells improve the chemical environment in the back of the eye,” said Ray Lund of the Casey Eye Institute at Oregon Health & Science University in Portland, whose findings were presented at the Society for Neuroscience meeting in Chicago.
AIIMS-Patna achieved a major feat on Wednesday by performing first stem cell therapy in Bihar. A very rare experiment done in select hospitals of the country, stem cells therapy was performed on a Chhapra patient whose spinal cord has been damaged.
Stem cell therapy includes impregnation of cells of bone marrow in a patient. It is done in cases when all other therapies fail to repair the damaged cells of an organ. On Wednesday morning, a team of AIIMS doctors extracted 190ml of bone marrow from the patient. A special kit was procured for the purpose by the institute from
Stem Cell Research for COPD and Emphysema
Dr. Roberto Fernandez Vina will present his stem cell study on Chronic Obstructive Pulmonary Disease (COPD) and Emphysema next week at the International Society for Stem Cell Research (ISSCR) annual meeting in Barcelona, Spain.
Dr. Fernandez Vina who is also the chairman of the Repair Stem Cell Institute’s Science […]
Novogen Limited, an oncology drug development company, today announced a collaboration with Australian company, Genea Biocells, to accelerate testing of their super-benzopyran (SBP) drugs for degenerative diseases of the nervous system and muscles.
Preliminary research conducted by both companies found that super-benzopyrans appear to be effective at promoting the ‘normalization’ of stem cells associated with some forms of neurodegeneration and muscular dystrophy, genetic disorders which result in progressive deterioration of brain function or muscle strength and function.
“SBPs have already been shown to be highly effective at killing cancer stem cells, which were previously considered resistant to anti-cancer therapy.
But in some
Are any stem cell treatments approved in the U.S.?
FDA has not approved any stem cell-based products for use, other than cord blood-derived hematopoietic progenitor cells (blood forming stem cells) for certain indications including certain blood cancers and some inherited metabolic and immune system disorders.
What should consumers know before being treated with therapies derived from stem cells?
As is the case with any investigational treatment, consumers should speak with their doctor to learn about the potential risks and benefits from being treated with a stem cell-based product. Consumers should seek assurance from their treating physician that necessary FDA approval has been